Navigation Links
First New OTC Headache Brand in 15 Years; Renowned Doctor Introduces Powerful Headache Medicine

Powerful headache medicine, Dr. Mauskop's Migralex, developed by Dr. Alexander Mauskop, renowned headache expert and founder of the New York Headache Center is now available to America’s 100 million headache sufferers, only 29 percent of whom are satisfied with their current headache treatments.

New York, NY (Vocus) January 11, 2010 -- A powerful headache medicine developed by a leading neurologist for his own patients is now available to America’s 100 million headache sufferers, only 29 percent of whom are satisfied with their current headache treatments.

Dr. Alexander Mauskop, renowned headache expert and founder of the New York Headache Center is the creator of Dr. Mauskop’s Migralex™, the strongest combination headache medicine available without a prescription.

Rather than relying on drugs that simply diminish discomfort, Dr. Mauskop’s Migralex™ targets stubborn pain at its source, correcting metabolic imbalances that trigger headaches. This innovative strategy brings quick relief, while freeing patients from the potential complications that accompany many popular medicines.

“I didn’t want my patients to suffer from the serious side effects seen with many headache drugs, problems like agitation, anxiety, insomnia, nausea, muscle cramps and headaches that become even worse,” explains Dr. Mauskop, a long-time headache sufferer himself.

“Headaches can drive you up the wall and make you try all sorts of medications. But sooner or later you’ll probably come to the conclusion that I did, that modern medicine doesn’t always give us what we seek: safe, reliable control over pain.”

Convinced there had to be a better way, Dr. Mauskop launched a 20-year quest to uncover the cause of headaches and to find alternatives to conventional drugs. His breakthrough research, conducted with Drs. Bella and Burton Altura, revealed that many headache sufferers share a common magnesium deficiency that results in a variety of neurochemical abnormalities. These imbalances cause brain and blood vessel changes in the head that trigger pain.

The doctor created a formula that combines precise amounts of quickly dissolving ingredients capable of delivering fast results with minimal side effects.

Those lucky enough to try the new approach quickly dubbed it a “miracle,” “effective” and “excellent.” However, as word of Dr. Mauskop’s research spread to professional journals, fellow physicians, national media outlets, and headache sufferers everywhere, the clamor for the new medication grew. The doctor answered the call with the release of his over-the-counter product.

“I introduced this patented medicine because I want to help more headache suffers than just my patients,” underlines Dr. Mauskop.

Now, everyone can take two caplets with a full glass of water to experience the relief previously enjoyed only by patients at the respected New York Headache Center.

Dr. Mauskop’s Migralex™ is fast acting, free of sodium, caffeine and preservatives, and is clinically proven to ease headaches brought on by sinus pain, stress, tension, menstruation, and exertion. The formula reduces inflammation, inhibits the clumping together of platelets, relaxes blood vessels and normalizes dozens of chemical reactions, while successfully and rapidly attacking pain.

With Dr. Mauskop’s Migralex™ widely available at the and websites and at select local pharmacies, the product’s originator is thrilled that many more people can enjoy genuine relief.

“There is simply no reason to be sidelined with an awful headache when such a quick, safe and effective medication is available,“ Dr. Mauskop concludes.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Better Hearing Institute Publishes First Comprehensive Guide to Financial Assistance for Hearing Aids
2. Sudden Cardiac Arrest Foundation Launches First Virtual Affiliate
3. First of Its Kind Website Makes History in a New Industry
4. Swine Flu Not As Infectious Among Young Adults As First Feared
5. THIN ADVENTURE(TM) Presents the First Childrens Do-It-Yourself Weight-Loss Program
6. Applied Technology Holdings, Inc. Forms First New Subsidiary Called MVP Sports Technologies, Inc.
7. A Promise to Keep. Senate Vote is the First Step Toward the Promise of Quality, Affordable Health Care for All
8. Twas the Night Before Christmas: First Lady Michelle Obama Reads the Holiday Classic
9. 2009: A Year of Many Firsts in Efforts to Overcome Lupus
10. American University of Antigua Becomes First International School to Administer Web-Based NBME Exam
11. Firsthand Knowledge of E85 Earns Waconia Man a Free Trip to Soldier Field to See Monday Night Vikings-Bears Game
Post Your Comments:
Related Image:
First New OTC Headache Brand in 15 Years; Renowned Doctor Introduces Powerful Headache Medicine
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: